Correlation Between Pfizer and PRAXAIR

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pfizer and PRAXAIR at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pfizer and PRAXAIR into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pfizer Inc and PRAXAIR INC 355, you can compare the effects of market volatilities on Pfizer and PRAXAIR and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pfizer with a short position of PRAXAIR. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pfizer and PRAXAIR.

Diversification Opportunities for Pfizer and PRAXAIR

0.23
  Correlation Coefficient

Modest diversification

The 3 months correlation between Pfizer and PRAXAIR is 0.23. Overlapping area represents the amount of risk that can be diversified away by holding Pfizer Inc and PRAXAIR INC 355 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PRAXAIR INC 355 and Pfizer is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pfizer Inc are associated (or correlated) with PRAXAIR. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PRAXAIR INC 355 has no effect on the direction of Pfizer i.e., Pfizer and PRAXAIR go up and down completely randomly.

Pair Corralation between Pfizer and PRAXAIR

Considering the 90-day investment horizon Pfizer Inc is expected to under-perform the PRAXAIR. But the stock apears to be less risky and, when comparing its historical volatility, Pfizer Inc is 86.68 times less risky than PRAXAIR. The stock trades about -0.08 of its potential returns per unit of risk. The PRAXAIR INC 355 is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  8,510  in PRAXAIR INC 355 on September 3, 2024 and sell it today you would lose (519.00) from holding PRAXAIR INC 355 or give up 6.1% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy38.18%
ValuesDaily Returns

Pfizer Inc  vs.  PRAXAIR INC 355

 Performance 
       Timeline  
Pfizer Inc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.
PRAXAIR INC 355 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days PRAXAIR INC 355 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest abnormal performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for PRAXAIR INC 355 investors.

Pfizer and PRAXAIR Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pfizer and PRAXAIR

The main advantage of trading using opposite Pfizer and PRAXAIR positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pfizer position performs unexpectedly, PRAXAIR can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PRAXAIR will offset losses from the drop in PRAXAIR's long position.
The idea behind Pfizer Inc and PRAXAIR INC 355 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..

Other Complementary Tools

Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites